[FG] Heinzelmann Viola

Lischetti, Ulrike et al. (2026) ‘Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming’, Nature Communications, 17. Available at: https://doi.org/10.1038/s41467-025-67557-z.

Mehra, Tarun et al. (2026) ‘Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer – results from the Tumor Profiler Melanoma project’, Npj Precision Oncology, 10. Available at: https://doi.org/10.1038/s41698-025-01229-5.

Geiger, J. et al. (2026) ‘Impact of maternal physical activity on outcome of assisted reproduction’, Frontiers in Endocrinology, 17. Available at: https://doi.org/10.3389/fendo.2026.1893897.

Jacob, F. et al. (2026) ‘A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy’, Nature Communications [Preprint]. Available at: https://doi.org/10.1038/s41467-026-74585-w.

Nonchev, K. et al. (2026) ‘Representation learning for multi-modal spatially resolved transcriptomics data’, Bioinformatics. Edited by Uhlmann, Virginie, 42(7). Available at: https://doi.org/10.1093/bioinformatics/btag316.

Cokan, A. et al. (2026) ‘Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows’, 36. Available at: https://doi.org/10.1016/j.ijgc.2026.104734.

Oelgarth, N. et al. (2026) ‘Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity’, Journal for ImmunoTherapy of Cancer, 14(7), p. e015090. Available at: https://doi.org/10.1136/jitc-2026-015090.

Zwimpfer, T.A. et al. (2026) ‘Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical society’, International Journal of Gynecological Cancer [Preprint]. Available at: https://doi.org/10.1016/j.ijgc.2026.104809.

Woopen, H. et al. (2026) ‘Patients’ Perception of Follow-Up Care and Personal Health Status of 677 Long-Term Survivors of Gynecological Cancer from the Study “Expression IX—Long-Term Survival with Gynecological Cancer”: The International NOGGO, ENGOT and GCIG Survey’, 18. Available at: https://doi.org/10.3390/cancers18101647.

Dimitrova, D. et al. (2026) ‘Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study “Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer”: The International NOGGO, ENGOT, and GCIG Survey’, Cancers, 18(7), p. 1183. Available at: https://doi.org/10.3390/cancers18071183.

Heidinger, M. et al. (2026) ‘Immunotherapy advancements in high-grade serous ovarian cancer: From promise to practice’, Critical Reviews in Oncology/Hematology [Preprint]. Available at: https://doi.org/10.1016/j.critrevonc.2026.105312.

Tal, O. et al. (2026) ‘Heterogeneity in Stage IV Ovarian Cancer: Survival Trends in Patients Presenting with Sister Mary Joseph’s Nodule’, 18. Available at: https://doi.org/10.3390/cancers18060897.

Labrosse, Kathrin B. et al. (2026) ‘Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer’, npj Precision Oncology [Preprint]. Available at: https://doi.org/10.1038/s41698-026-01321-4.

Canário, Rita et al. (2026) ‘P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma’, Virchows Archiv, 488. Available at: https://doi.org/10.1007/s00428-025-04104-7.

Gosztonyi, Benedict et al. (2026) ‘Safety of Multi-Omics–Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis’, JCO Precision Oncology, 10(1). Available at: https://doi.org/10.1200/po-25-00896.

Estrada, Marta F. et al. (2026) ‘zAvatar-test—A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical study’, Cell Reports Medicine, 7, p. 102530. Available at: https://doi.org/10.1016/j.xcrm.2025.102530.

Frei, Céline Arlette et al. (2026) ‘The chromatin guardian ATRX is a strong prognostic biomarker in melanoma’, Scientific Reports. 18.12.2025, 16. Available at: https://doi.org/10.1038/s41598-025-30842-4.

Ge, Isabell et al. (2026) ‘Integrative Medizin bei Brust- und gynäkologischen Krebserkrankungen – am Beispiel des Universitätsspitals Basel’, Onkologiepflege, 2026(1), pp. 10–12.

Bollhagen, Alina et al. (2025) ‘High-resolution imaging mass cytometry to map subcellular structures’, Nature Methods, 22(12), pp. 2601–2608. Available at: https://doi.org/10.1038/s41592-025-02889-8.

Vigo, Francesco et al. (2025) ‘Binary classification of gynecological cancers based on ATR-FTIR spectroscopy and machine learning using urine samples’, Clinical and Experimental Medicine, 25. Available at: https://doi.org/10.1007/s10238-025-01684-1.

Petousis, Stamatios et al. (2025) ‘PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis’, JAMA Network Open, 8(11). Available at: https://doi.org/10.1001/jamanetworkopen.2025.41648.

Eugster-Disler, Muriel et al. (2025) ‘Cesarean scar niche repair with the rendez-vous technique: comparison of pre- and postoperative symptoms, sonographic findings and quality of life’, European Journal of Obstetrics and Gynecology and Reproductive Biology, 313. Available at: https://doi.org/10.1016/j.ejogrb.2025.114566.

Knauer, Michael et al. (2025) ‘Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57–18, ABCSG-53, GBG 101)’, European Journal of Cancer, 225. Available at: https://doi.org/10.1016/j.ejca.2025.115585.

Christinat, Yann et al. (2025) ‘Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit from Olaparib and Bevacizumab Maintenance in Ovarian Cancer’, JCO Precision Oncology, 9. Available at: https://doi.org/10.1200/po-24-00825.

Todorov, Tihomir Zh. et al. (2025) ‘161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer’, Journal of Nuclear Medicine, 66, pp. 1091–1096. Available at: https://doi.org/10.2967/jnumed.124.269078.

Casanova, Ruben et al. (2025) ‘Standardization of Suspension and Imaging Mass Cytometry Single-Cell Readouts for Clinical Decision Making’, Cytometry Part A, 107, pp. 390–403. Available at: https://doi.org/10.1002/cyto.a.24940.

Einig, Sabrina et al. (2025) ‘External validation of the IOTA two-step strategy in the preoperative characterization of ovarian masses’, European Journal of Obstetrics and Gynecology and Reproductive Biology, 310. Available at: https://doi.org/10.1016/j.ejogrb.2025.113981.

Chinczewski, Lukas et al. (2025) ‘Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer’, Archives of Gynecology and Obstetrics, 311, pp. 1445–1450. Available at: https://doi.org/10.1007/s00404-025-07991-y.

Pölcher, Martin et al. (2025) ‘Intergroup statement: opportunistic salpingectomy—molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss)’, Archives of Gynecology and Obstetrics, 311, pp. 1451–1459. Available at: https://doi.org/10.1007/s00404-025-07974-z.

Todorov, Tihomir Zh et al. (2025) ‘Phosphoproteomics Reveals L1CAM-Associated Signaling Networks in High-Grade Serous Ovarian Carcinoma: Implications for Radioresistance and Tumorigenesis’, International Journal of Molecular Sciences, 26. Available at: https://doi.org/10.3390/ijms26104585.

Zwimpfer, Tibor A. et al. (2025) ‘TP53 Mutations and Phosphatidylinositol 3-Kinase/AKT Pathway Alterations Are Key Determinants of Breast Cancer Outcome Independent of Subtype and Stage’, JCO Precision Oncology, 9. Available at: https://doi.org/10.1200/po-24-00767.

Dondi, Arthur et al. (2025) ‘De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing data’, Genome Research, 35, pp. 900–913. Available at: https://doi.org/10.1101/gr.279281.124.

Vergote, Ignace et al. (2025) ‘Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study’, European Journal of Cancer, 219. Available at: https://doi.org/10.1016/j.ejca.2025.115306.

Kavvadias, Tilemachos, Gosch, Emma Garcia and Heinzelmann-Schwarz, Viola (2025) ‘Robotic assisted hysterectomy and colpectomy as gender affirming surgery in trans men: an instructional video and perioperative considerations’, Frontiers in Surgery, 12. Available at: https://doi.org/10.3389/fsurg.2025.1608666.

Einig, Sabrina et al. (2024) ‘Impact of Sonographer Experience, Insonation Angle, and Bladder Filling on Uterine Artery Doppler Measurements in the First Trimester of Pregnancy’, Journal of Ultrasound in Medicine, 43(12), pp. 2375–2383. Available at: https://doi.org/10.1002/jum.16572.

Förster, Christiane E. et al. (2024) ‘Comparison of different suture techniques for laparoscopic vaginal cuff closure’, Scientific Reports, 14(1). Available at: https://doi.org/10.1038/s41598-024-55586-5.

Gottfrois, Philippe et al. (2024) ‘AI-powered visual diagnosis of vulvar lichen sclerosus: A pilot study’, Journal of the European Academy of Dermatology and Venereology, 38(12), pp. 2280–2285. Available at: https://doi.org/10.1111/jdv.20306.

Kasikova, Lenka et al. (2024) ‘Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-024-46873-w.

Zwimpfer, Tibor A. et al. (2024) ‘Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems in bariatric surgery: study protocol for a randomized controlled prospective trial’, Trials, 25(1). Available at: https://doi.org/10.1186/s13063-024-07983-4.

Tundo, Sofia et al. (2024) ‘Inhibition of Cbl-b restores effector functions of human intratumoral NK cells’, Journal for ImmunoTherapy of Cancer, 12(11). Available at: https://doi.org/10.1136/jitc-2024-009860.

Speck, Nicole E. et al. (2024) ‘The Importance of Patient-Reported Outcome Measures (PROMs) in Oncological Vulvoperineal Defect Reconstruction: A Systematic Review’, Current Oncology. 25.10.2024, 31(10), pp. 6300–6313. Available at: https://doi.org/10.3390/curroncol31100470.

Zwimpfer, Tibor A et al. (2024) ‘Predictive value of homologous recombination deficiency status for survival outcomes in primary tubo-ovarian high-grade serous carcinoma’, Cochrane Database of Systematic Reviews. 23.09.2024, 2024(9). Available at: https://doi.org/10.1002/14651858.cd015896.

Labrosse, Kathrin B. et al. (2024) ‘Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models’, STAR Protocols, 5(3). Available at: https://doi.org/10.1016/j.xpro.2024.103274.

Colombo, N. et al. (2024) ‘Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial’, 25. Available at: https://doi.org/10.1016/s1470-2045(24)00334-6.

Einig, S. et al. (2024) ‘Präoperative sonographische Beurteilung von Adnexbefunden mittels Ovarian-Adnexal Reporting & Data System (O-RADS)’, in Ultraschall in der Medizin - European Journal of Ultrasound. Salzburg (Ultraschall in der Medizin - European Journal of Ultrasound). Available at: https://doi.org/10.1055/s-0044-1789121.

Heidinger, Martin et al. (2024) ‘Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery – A retrospective cohort study’, European Journal of Surgical Oncology, 50(9), pp. 1–9. Available at: https://doi.org/10.1016/j.ejso.2024.108478.

Cumin, Cécile et al. (2024) ‘Highly Sensitive Spatial Glycomics at Near-Cellular Resolution by On-Slide Derivatization and Mass Spectrometry Imaging’, Analytical Chemistry, 96(28), pp. 11163–11171. Available at: https://doi.org/10.1021/acs.analchem.3c05984.

Montagna, Giacomo et al. (2024) ‘Omission of Axillary Dissection Following Nodal Downstaging with Neoadjuvant Chemotherapy’, JAMA Oncology. 25.04.2024, 10(6), pp. 793–798. Available at: https://doi.org/10.1001/jamaoncol.2024.0578.

Wendelspiess, Séverin et al. (2024) ‘Perforator versus Non-Perforator Flap-Based Vulvoperineal Reconstruction—A Systematic Review and Meta-Analysis’, Cancers. 13.06.2024, 16(12). Available at: https://doi.org/10.3390/cancers16122213.

Grašič Kuhar, Cvetka et al. (2024) ‘Prognostic Importance of Axillary Lymph Node Response to Neoadjuvant Systemic Therapy on Axillary Surgery in Breast Cancer—A Single Center Experience’, Cancers, 16(7). Available at: https://doi.org/10.3390/cancers16071306.

Harter, Philipp et al. (2024) ‘Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer’, Bulletin du Cancer, 111(3), pp. 277–284. Available at: https://doi.org/10.1016/j.bulcan.2023.02.011.

Zwimpfer, Tibor A. et al. (2024) ‘Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO)’, Cancers, 16(6). Available at: https://doi.org/10.3390/cancers16061155.

Labrosse, Kathrin B. et al. (2024) ‘Intracorporeal vs. extracorporeal open and closed knot tying techniques in laparoscopy: A randomized, controlled study’, Heliyon. 26.01.2024, 10(3), p. e25178. Available at: https://doi.org/10.1016/j.heliyon.2024.e25178.

Stiegeler, Nadja et al. (2024) ‘Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group’, Frontiers in Oncology, 14. Available at: https://doi.org/10.3389/fonc.2024.1387281.

Weber, Walter P. et al. (2024) ‘Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)’, Annals of Surgical Oncology. 30.10.2023, 31(1), pp. 344–355. Available at: https://doi.org/10.1245/s10434-023-14404-4.

Zwimpfer, T.A. et al. (2024) ‘Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers’, Cancer Medicine, 13(1). Available at: https://doi.org/10.1002/cam4.6840.

Herzog, Emilie M et al. (2023) ‘How to break bad news and how to learn this skill: Results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians andthe physicians are generally alone with the patient; Only 57.4% medical students with 1089 participants’, International Journal of Gynecological Cancer, 33(12), pp. 1934–1942. Available at: https://doi.org/10.1136/ijgc-2023-004693.

Zwimpfer, Tibor A. et al. (2023) ‘Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event’, World Journal of Surgical Oncology, 21(1). Available at: https://doi.org/10.1186/s12957-023-02918-w.

Woopen, Hannah et al. (2023) ‘Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey’, Cancers, 15(22). Available at: https://doi.org/10.3390/cancers15225428.

Knipprath-Mészáros, Alexandra Maria et al. (2023) ‘High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma’, Gynecologic Oncology, 174, pp. 182–189. Available at: https://doi.org/10.1016/j.ygyno.2023.05.005.

Colombo, N. et al. (2023) ‘INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line’, British Journal of Cancer, 128(8), pp. 1503–1513. Available at: https://doi.org/10.1038/s41416-022-02108-7.

Estermann, Manuela et al. (2023) ‘A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasis’, Biomaterials, 294. Available at: https://doi.org/10.1016/j.biomaterials.2023.121996.

Martinez, Alejandra et al. (2023) ‘PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): A GINECO, ENGOT, and GCIG study’, International Journal of Gynecological Cancer, 33(2), pp. 293–298. Available at: https://doi.org/10.1136/ijgc-2022-004223.

Zwimpfer, Tibor A. et al. (2023) ‘Low grade serous ovarian cancer – A rare disease with increasing therapeutic options’, Cancer Treatment Reviews, 112, p. 102497. Available at: https://doi.org/10.1016/j.ctrv.2022.102497.

McLaughlin PMJ et al. (2022) ‘Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial’, BMC Cancer, 22(1), p. 508. Available at: https://doi.org/10.1186/s12885-022-09555-8.

Schwab, Fabienne D. et al. (2022) ‘MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies’, Microsystems and Nanoengineering, 8(1). Available at: https://doi.org/10.1038/s41378-022-00467-y.

Steffens D et al. (2022) ‘The double S technique to achieve aesthetic flat closure after conventional mastectomy’, World Journal of Surgical Oncology, 20(1), p. 42. Available at: https://doi.org/10.1186/s12957-022-02515-3.

Natoli, Marina et al. (2022) ‘Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors’, Journal for ImmunoTherapy of Cancer, 10(11). Available at: https://doi.org/10.1136/jitc-2022-005548.

Vetter, Marcus et al. (2022) ‘Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment’, International Journal of Molecular Sciences, 23(22). Available at: https://doi.org/10.3390/ijms232214242.

Coelho, Ricardo et al. (2022) ‘Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer’, Cell Death and Disease, 13(10), p. 909. Available at: https://doi.org/10.1038/s41419-022-05347-x.

Chase DM et al. (2022) ‘Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial’, Gynecologic Oncology, 166(3), pp. 494–502. Available at: https://doi.org/10.1016/j.ygyno.2022.06.028.

Cumin C et al. (2022) ‘Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways’, Cell Reports, 40(7), p. 111181. Available at: https://doi.org/10.1016/j.celrep.2022.111181.

Diamantopoulou Z et al. (2022) ‘The metastatic spread of breast cancer accelerates during sleep’, Nature, 607(7917), pp. 156–162. Available at: https://doi.org/10.1038/s41586-022-04875-y.

Fedier A et al. (2022) ‘Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines’, International Journal of Oncology, 61(1). Available at: https://doi.org/10.3892/ijo.2022.5379.

Filippi V et al. (2022) ‘Extramedullary haematopoiesis presenting as an adnexal mass in a patient with β-thalassaemia’, BMJ Case Reports, 15(6). Available at: https://doi.org/10.1136/bcr-2022-249422.

Zwimpfer TA et al. (2022) ‘Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems using a pelvitrainer model: a randomized controlled study’, Updates in Surgery, 74(3), pp. 1137–1147. Available at: https://doi.org/10.1007/s13304-021-01195-0.

Ehrbar V. et al. (2022) ‘Managing Cancer as a Family Disease - Feasibility, Satisfaction and Family Functioning after Short-Time Counselling for Families with Parental Cancer’, Family Journal, 30(2), pp. 200–208. Available at: https://doi.org/10.1177/10664807211052484.

Vigo F et al. (2022) ‘An interdisciplinary team-training protocol for robotic gynecologic surgery improves operating time and costs: analysis of a 4-year experience in a university hospital setting’, Journal of Robotic Surgery, 16(1), pp. 89–96. Available at: https://doi.org/10.1007/s11701-021-01209-4.

Amstad Gabriela et al. (2022) ‘Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER- Study): study protocol for a single-blind, mono-centre, randomized study’, BMJ Open, 12(9). Available at: https://doi.org/10.1136/bmjopen-2021-057381.

Felder L, Heinzelmann-Schwarz V and Kavvadias T (2022) ‘How does colpocleisis for pelvic organ prolapse in older women affect quality of life, body image, and sexuality? A critical review of the literature’, Women’s Health, 18, p. 17455057221111067. Available at: https://doi.org/10.1177/17455057221111067.

Sarki, Mahesh. et al. (2022) ‘Intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and lynch syndrome: the Swiss CASCADE Cohort’, Cancers. 23.03.2022, 14(7). Available at: https://doi.org/10.3390/cancers14071636.

Sobottka, Bettina et al. (2021) ‘Establishing standardized immune phenotyping of metastatic melanoma by digital pathology’, Laboratory Investigation, 101(12), pp. 1561–1570. Available at: https://doi.org/10.1038/s41374-021-00653-y.

Fischerova D et al. (2021) ‘Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group’, in Ultrasound in Obstetrics and Gynecology. John Wiley and Sons Ltd (Ultrasound in Obstetrics and Gynecology), pp. 861–879. Available at: https://doi.org/10.1002/uog.23617.

Koelzer VH et al. (2021) ‘Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform’, Immuno-Oncology and Technology, 10. Available at: https://doi.org/10.1016/j.iotech.2021.100034.

Irmisch, Anja et al. (2021) ‘The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support’, Cancer Cell, 39(3), pp. 288–293. Available at: https://doi.org/10.1016/j.ccell.2021.01.004.

Heinzelmann-Schwarz, Viola (2021) ‘Recent advances in breast cancer’, Schweizer Zeitschrift fur Gynakologie, null, p. 1.

Heinzelmann-Schwarz, Viola (2021) ‘Editorial’, Schweizer Zeitschrift fur Gynakologie, null, p. 1.

Jacob F et al. (2021) ‘High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer’, Molecular Oncology, 15(1), pp. 91–103. Available at: https://doi.org/10.1002/1878-0261.12811.

Kim, Sue et al. (2021) ‘Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study’, JMIR Research Protocols. 11.06.2021, 10(6). Available at: https://doi.org/10.2196/26264.

Sartorius, Céline Montavon and Heinzelmann-Schwarz, Viola (2021) ‘Treatment of Epithelial Ovarian Cancers, Fallopian Tube Cancers and Peritoneal Surface Cancers’, in Ebcog Postgraduate Textbook of Obstetrics and Gynaecology Gynaecology. (The EBCOG Postgraduate Textbook of Obstetrics and Gynaecology: Gynaecology), pp. 357–365. Available at: https://doi.org/10.1017/9781108582322.043.

Sartorius, Céline Montavon and Heinzelmann-Schwarz, Viola (2021) ‘Diagnosis of Epithelial Ovarian, Fallopian Tubal and Peritoneal Surface Cancers’, in Ebcog Postgraduate Textbook of Obstetrics and Gynaecology Gynaecology. (The EBCOG Postgraduate Textbook of Obstetrics and Gynaecology: Gynaecology), pp. 348–356. Available at: https://doi.org/10.1017/9781108582322.042.

Zeiter D et al. (2021) ‘L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy’, Journal of Cancer, 12(21), pp. 6401–6410. Available at: https://doi.org/10.7150/jca.59283.

Trüb M et al. (2020) ‘Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer’, Journal for ImmunoTherapy of Cancer, 8(2). Available at: https://doi.org/10.1136/jitc-2019-000238.

Coelho R et al. (2020) ‘Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation’, Oncogenesis, 9(6), p. 61. Available at: https://doi.org/10.1038/s41389-020-00246-2.

Heinzelmann-Schwarz V et al. (2020) ‘Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?’, Journal of Cancer Research and Clinical Oncology, 146(3), pp. 695–704. Available at: https://doi.org/10.1007/s00432-019-03091-y.

Wieser S et al. (2020) ‘Reply to comment on: Wieser et al. Ovarian cancer in Switzerland: Incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647’, Swiss Medical Weekly. EMH Schweizerischer Arzteverlag AG, 150(5-6). Available at: https://doi.org/10.4414/smw.2020.20180.

Le Page C et al. (2020) ‘Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis’, Gynecologic Oncology, 156(2), pp. 377–386. Available at: https://doi.org/10.1016/j.ygyno.2019.11.019.

Huang, Yen-Lin et al. (2020) ‘Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis’, eLife, 9, p. e59442. Available at: https://doi.org/10.7554/elife.59442.

Montagna G et al. (2020) ‘The impact of depression on adherence to organized and opportunistic breast cancer screening’, European Journal of Cancer Prevention, 29(1), pp. 53–59. Available at: https://doi.org/10.1097/cej.0000000000000520.

Terraneo N et al. (2020) ‘L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population’, Cancers, 12(1). Available at: https://doi.org/10.3390/cancers12010217.